×
About 83,990 results

ALLMedicine™ Headache Center

Research & Reviews  19,093 results

The vascular architecture of cavernous sinus dural arteriovenous fistula and its impact...
https://doi.org/10.1016/j.wneu.2022.07.094
World Neurosurgery; Liu P, Liu Y et. al.

Aug 7th, 2022 - A cavernous sinus dural arteriovenous fistula (CS-DAVF) is a form of abnormal arteriovenous communication that can be treated with endovascular embolization. Establishing an optimal access route should be based on vascular architecture. We reviewe...

Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder...
https://doi.org/10.1016/j.jad.2022.07.068
Journal of Affective Disorders; Deligiannidis KM, Robakis T et. al.

Aug 7th, 2022 - Postpartum depression has a high prevalence in the United States (~13 %) and often goes undertreated/untreated. We conducted a multicenter, open-label, proof-of-concept trial to assess the Nēsos wearable, non-invasive, transcutaneous auricular vag...

Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse...
https://doi.org/10.1007/s11060-022-04077-6
Journal of Neuro-oncology; Hollingworth M, Zacharoulis S

Aug 7th, 2022 - Side-effects during convection enhanced delivery (CED) are poorly understood. We intended to determine the frequency of side-effects during brain stem infusion and determine risk factors for side-effects persisting longer than 24 h. Children with ...

Exploring the trajectory curve of long-term musculoskeletal post-COVID pain symptoms in...
https://doi.org/10.1097/j.pain.0000000000002718
Pain Fernandez-de-Las-Penas C, Cancela-Cilleruelo I et. al.

Aug 6th, 2022 - This multicenter cohort study investigated the prevalence of musculoskeletal post-COVID pain during the first year after the infection with mosaic plots and an exponential bar plot model and its associated risk factors. Patients hospitalized becau...

Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefite...
https://doi.org/10.1007/s12325-022-02233-y
Advances in Therapy; Ailani J, Andrews JS et. al.

Aug 6th, 2022 - In evaluating therapies for migraine prevention, emphasis is placed on frequency and less attention is paid to duration or severity. Total pain burden (TPB) combines frequency, duration, and severity of migraine headache, and has the potential to ...

see more →

Guidelines  31 results

Headaches in Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 3.
https://doi.org/10.1097/AOG.0000000000004766
Obstetrics and Gynecology;

May 17th, 2022 - To provide updated evidence-based recommendations for the evaluation and treatment of primary and secondary headaches in pregnancy and postpartum. Pregnant and postpartum patients with a history of or experiencing primary or new secondary headache...

Nutritional Approaches for Musculoskeletal Pain and Inflammation: What the Science Says
https://www.nccih.nih.gov/health/providers/digest/nutritional-approaches-for-musculoskeletal-pain-and-inflammation-science?nav=govdcd
NCCIH Clinical Digestfor Health Professionals;

Feb 28th, 2022 - Willow bark has been used for centuries as a treatment for pain, headache, and inflammatory conditions such as bursitis and tendinitis. The bark of white willow contains salicin, the chemical that was used to develop aspirin. Despite its long hist...

Nervous system consequences of COVID-19
https://www.science.org/doi/10.1126/science.abm2052
Science Spudich S, Nath A.

Jan 20th, 2022 - Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a respiratory pathogen, myriad neurologic complications—including confusion, stroke, and neuromuscular disorders—manifest during acute COVID-19. Furthermore, malad...

Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787361
JAMA Network Open; Beatty AL, Peyser ND et. al.

Dec 22nd, 2021 - In December 2020, the first COVID-19 vaccines received emergency use authorization in the United States.1,2 Billions of doses of vaccine have been administered worldwide.3 However, some individuals have concerns about receiving COVID-19 vaccinatio...

Editorial. Valuing headache's solution.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171396
The Journal of Headache and Pain; Steiner TJ, Tinelli M

Jun 12th, 2021 - Editorial. Valuing headache's solution.|2021|Steiner TJ,Tinelli M,|diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & control,diagnosis,prevention & co...

see more →

Drugs  7,528 results see all →

Clinicaltrials.gov  1,925 results

Eptinezumab in Adults With Migraine and Medication Overuse Headache
https://clinicaltrials.gov/ct2/show/NCT04772742

Aug 5th, 2022 - Patients planned for randomization: 91 patients in the eptinezumab 100 mg group and 91 patients in the placebo group. The total study duration from the Screening Visit to the Safety Follow-up Visit is approximately 36 weeks and includes a Screenin...

Spinal Prilocaine for Caesarian Sections
https://clinicaltrials.gov/ct2/show/NCT03219086

Aug 5th, 2022 - This study is designed as a randomised prospective double blind multi centre study. Following approval by the Hospital Ethics committee of the University Hospital Antwerp and all participating hospitals, all-in term (37-42 weeks of gestation) preg...

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
https://clinicaltrials.gov/ct2/show/NCT05064397

Aug 5th, 2022 - The participants who take part in this trial will be asked to stay in the trial for about a year. The participants will be asked to visit the trial site 7 times during the trial. In between trial site visits, they will have scheduled phone calls w...

NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
https://clinicaltrials.gov/ct2/show/NCT05375812

Aug 5th, 2022 - Study Description: This protocol is part of a joint collaboration with the Veterans Administration (VA) known as (Project IN-DEPTH). The Veterans Administration protocol will recruit and identify participants for the NIH study, and maintain a repo...

Validity of Headache Disability Index
https://clinicaltrials.gov/ct2/show/NCT05376163

Aug 4th, 2022 - Headache is a health problem that is reported to occur in 66% of the global population, reducing both quality of life and work productivity. The most common type is tension headache with a prevalence of 38%, followed by migraine headaches with 10%...

see more →

News  4,772 results

A 27-Year-Old Woman With Constant Headache Too Tired to Party
https://www.medscape.com/viewarticle/977791

Aug 8th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Peer Pressure Can Help Trim Opioid Orders
https://www.medscape.com/viewarticle/978595

Aug 4th, 2022 - When it comes to reducing opioid prescriptions for patients with pain, peer pressure is a powerful force. A system that offers clinicians a look at how often their fellow physicians prescribe opioids to patients with noncancer pain led to signific...

Is it psychosis, or an autoimmune encephalitis?
https://www.mdedge.com/psychiatry/article/256618/schizophrenia-other-psychotic-disorders/it-psychosis-or-autoimmune
Matthew L. Baum, MD, PhD, DPhil, Matthew Carriero Johnson, MD et. al.

Aug 1st, 2022 - Hidden within routine presentations of first-episode psychosis is a rare subpopulation whose symptoms are mediated by an autoimmune process for which proper treatment differs significantly from standard care for typical psychotic illness. In this.

Episodes of visual disturbance
https://www.mdedge.com/migraine-challenge-center/article/256718/migraine/episodes-visual-disturbance

Aug 1st, 2022 - On the basis of the history, examination, and investigations, retinal migraine was diagnosed according to the International Classification of Headache Disorders, third edition (1. 2 migraine with aura; 1.

Efficacy and safety of external concurrent occipital and trigeminal neurostimulation in migraine treatment
https://www.mdedge.com/migraine-icymi/article/256671/headache-migraine/efficacy-and-safety-external-concurrent-occipital

Jul 31st, 2022 - Key clinical point: External concurrent occipital and trigeminal neurostimulation (eCOT-NS) was well tolerated, safe, and an effective treatment that provided fast and durable relief and freedom from pain in patients with migraine with or without.

see more →

Patient Education  247 results see all →